•   
  •   
  •   

Canada Why some say waiving COVID-19 vaccine patents could help fix disparity issues

14:41  10 may  2021
14:41  10 may  2021 Source:   cbc.ca

Canada is holding back its 1-shot J&J COVID-19 vaccine. Here’s what you need to know

  Canada is holding back its 1-shot J&J COVID-19 vaccine. Here’s what you need to know Health Canada on Friday said that they were holding back 300,000 doses of the one-shot J&J vaccine — mere days before they were meant to be deployed.On Friday, Health Canada announced it is holding back the J&J vaccine, a one-shot dose that experts and health officials touted as crucial in stemming the spread of the virus amid a devastating third wave of the pandemic, after it was revealed that parts of the batch were made in the same Baltimore plant where millions of other doses meant for the U.S. market had spoiled.

The world wants to put the coronavirus pandemic in the rear-view mirror, but that can't happen without a lot more people receiving vaccines.

The United States is supporting a push — proposed by India and South Africa last year — for countries to temporarily drop patent protections for COVID-19 vaccines so that more doses can be quickly manufactured and distributed around the globe.

Canada is willing to consider supporting the idea, although Prime Minister Justin Trudeau says he favours reaching a global consensus that takes into account the views of nations in need and also of drug makers.

But any potential waiving of patent protections would be just one piece in the complex puzzle of getting COVID-19 vaccines to all of the people who need them.

Canada ‘very closely’ watching data on mixing and matching COVID-19 vaccines

  Canada ‘very closely’ watching data on mixing and matching COVID-19 vaccines With hundreds of thousands of Canadians inoculated with one dose of AstraZeneca, and Canada's next shipment in flux, combining vaccines is quickly becoming a potential reality. Your browser does not support this video Tam suggested mixing might actually provide additional benefits, but stopped short of saying anything definitive, noting how quickly the science is evolving.

What would waiving patent protections do?

What the U.S. is supporting is a temporary waiving of the World Trade Organization's agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), a move proponents say would help boost vaccine production and benefit poorer countries in need of doses.

Matthew Herder, director of Dalhousie University's Health Law Institute in Halifax, said this waiver would clear the way for would-be vaccine producers to get on with the business of trying to make more doses.

a group of people looking at a phone: Manuel Santamaria, 76, receives a shot of the Pfizer vaccine during a COVID-19 vaccination campaign in Pamplona, Spain, on Friday. © Alvaro Barrientos/The Associated Press Manuel Santamaria, 76, receives a shot of the Pfizer vaccine during a COVID-19 vaccination campaign in Pamplona, Spain, on Friday.

"There are flexibilities built into law now that could help countries get around one patent at a time, but the waiver is a blunt instrument that promises to sidestep those kind of IP barriers much more efficiently," he told CBC News in a recent interview.

U.S. backs waiver on vaccine patents. What it means and what Canada thinks

  U.S. backs waiver on vaccine patents. What it means and what Canada thinks The U.S. and EU support is a 'signal that IP rights can legitimately be limited' during a health crisis like COVID-19, one expert said.The U.S. announced Wednesday it now supports a proposal to waive intellectual property (IP) protection to help boost the global COVID-19 vaccine supply. The European Union is also willing to discuss the waiver.

James Krellenstein, co-founder of the New York-based advocacy group PrEP4All, believes a patent waiver is a step in the right direction — something he hopes Canada will support.

"In a pandemic, we don't have any time, really, to have any barrier in place that could prevent the scale-up of manufacturing of vaccines," he told CBC News Network on Saturday. "Lives are on the line."

Vaccines needed internationally

a group of people standing in front of a crowd posing for the camera: People wearing face masks walk through the Shinjuku area of Tokyo on Friday. © Yuichi Yamazaki/Getty Images People wearing face masks walk through the Shinjuku area of Tokyo on Friday.

Vaccines are key to bringing an end to the pandemic, which has claimed more than 3.2 million lives around the globe, and that urgency isn't lost on the world leaders scrambling to source them.

That's why the European Commission wants the U.S. and other COVID-19 vaccine-producing countries to export much more of the vaccines they're making.

There are currently wide disparities when it comes to COVID-19 vaccine access and rates of vaccination.

NHL's COVID protocol-related absences for May 8, 2021

  NHL's COVID protocol-related absences for May 8, 2021 Players in the protocol are: Colorado's Devan Dubnyk and Washington's Evgeny Kuznetsov.Calgary – TBA

WHO Director-General Tedros Adhanom Ghebreyesus said on Thursday that some countries that signed up to the COVAX vaccine-sharing initiative had yet to receive any doses, none of the countries had received enough and some were not receiving their second-round vaccine allocations on time.

Ways of speeding up vaccine effort

a group of people standing in a kitchen: Workers inside German pharmaceutical plant Allergopharma, where the Pfizer-BioNTech COVID-19 vaccine is being produced, near Hamburg on April 30. © Christian Charisius/Reuters Workers inside German pharmaceutical plant Allergopharma, where the Pfizer-BioNTech COVID-19 vaccine is being produced, near Hamburg on April 30.

Prashant Yadav, a senior fellow at the non-profit think-tank Center for Global Development, said he sees a general need to bulk up worldwide vaccine-production capacity.

A patent waiver is one approach, but Yadav said for now it's probably most efficient for COVID-19 vaccine-makers to find manufacturing partners that can help make vaccines in parts of the world where those drug makers are not operational.

"That's the pathway, which is salient and proven," he told CBC News from Washington, D.C.

Yadav said that's how the AstraZeneca-Oxford vaccine has been able to be produced in India, for example.

Mix and match: Canadian officials watching the data on alternating COVID-19 vaccines

  Mix and match: Canadian officials watching the data on alternating COVID-19 vaccines As some experts continue to warn of very rare side effects associated with the AstraZeneca vaccine, Canadian health officials are now reviewing the research on mixing various COVID-19 shots. Here's what you need to know.A study of a "mismatched" vaccine regimen is underway in the U.K. — but some scientists say there's reason to believe that administering two doses of different products could boost a person's immune response beyond what can be achieved by giving the same shot twice.

"The patent pathway could in the medium or ... long term create more distributed manufacturing, could have more manufacturers spread around the world," he said, noting it's not a likely solution in the short term.

A need for continued innovation, production

Some industry voices have suggested a move to lift patent protections could discourage future vaccine investment, while others have suggested it won't solve the vaccine production and supply challenges any time soon.

Some political leaders are also opposed — including German Chancellor Angela Merkel, who reiterated her opposition to the idea on Saturday.

a close up of a person wearing a mask: German Chancellor Angela Merkel, in Berlin on Saturday, does not support using patent waivers as a method of driving up production of coronavirus vaccines. © John MacDougall/Reuters German Chancellor Angela Merkel, in Berlin on Saturday, does not support using patent waivers as a method of driving up production of coronavirus vaccines.

"I do not believe that giving away patents is the solution to make vaccines available to more people," Merkel said. "I believe that we need the creativity and innovation of those firms, and that is why I believe in a patent protection."

Merkel is among European leaders who favour leveraging the export of vaccines to other countries to get vaccine supplies to countries in need.

"No one will be safe until we all are. If vaccination takes place only in developed countries, our victory over COVID-19 will only be short-lived," the leaders of Belgium, Sweden, France, Denmark and Spain wrote in a joint letter to the European Commission.

"Vaccines have become security policy and the EU cannot afford to lag behind; to this end, an increased European production capacity will be a key priority," they said.

A laboratory employee works on the pilot production phase of Russia's Sputnik V vaccine for COVID-19 at the pharmaceutical company Uniao Quimica in Brasilia, Brazil, in January. © Eraldo Peres/The Associated Press A laboratory employee works on the pilot production phase of Russia's Sputnik V vaccine for COVID-19 at the pharmaceutical company Uniao Quimica in Brasilia, Brazil, in January.

COVID-19 Update: Where COVID-19 rates are highest in rural Alberta | Hinshaw to provide update at 3:30 p.m. .
With news on COVID-19 happening rapidly, we’ve created this page to bring you our latest stories and information on the outbreak in and around Calgary. What’s happening now Dr. Deena Hinshaw will deliver an update on COVID-19 case numbers at 3:30 p.m. today. Alberta reported Monday 721 new cases of COVID-19 on 7,002 tests and five additional deaths. Canada is set to receive a large infusion of COVID-19 vaccines this week, even as questions swirl around how the immunization drive will be affected by the sudden departure of the man tasked with overseeing it.

usr: 11
This is interesting!